PAF attenuates endothelium-dependent coronary arteriolar vasodilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 6 39-6, 1996, Pages

  DeFily, David V ^a,b   Kuo, Lih ^a   Chilian, William M ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

endothelium; neutrophil

Indexed keywords

ACETYLCHOLINE; PAPAVERINE; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY VASCULAR RESISTANCE; DOG; ENDOTHELIUM CELL; FEMALE; INTRACORONARY INFUSION; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; VIDEORECORDING;

EID: 33750801388     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.6.h2094     Document Type: Article

References (32)

1. Cappelli-Bigazzi, M., D. W. Nuno, and K. G. Lamping. Evidence of a role for compounds derived from arginine in coronary response to serotonin in vivo Am. J. Physiol. 261 (Heart Circ. Physiol 30): H404-H409, 1991.
2. Chilian, W. M., C. L. Eastham, and M. L. Marcus. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am. J. Physiol 251 (Heart Circ. Physiol. 20): H779-H788, 1986.
3. DeFily, D. V., and W. M. Chilian. Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H700-H706, 1993.
4. Dillon, P. K., M. F. Fitzpatrick, A. B. Ritter, and W. N. Durán. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships. Inflammation 12: 563-573, 1988.
5. Dillon, P. K., A. B. Ritter, and W. N. Durán. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose related relations and pathways of action. Circ. Res. 62: 722-731, 1988.
6. Durän, W. N., and P. K. Dillon. Acute microcirculatory effects of platelet-activating factor. J. Lipid Mediators 2: S215-S227, 1990.
7. Hirafuji, M., and H. Shinoda. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Br. J. Pharmacol. 103: 1333-1338, 1991.
8. Katoh, S., J. Toyama, I. Kodama, A. Koike, and T. Abe. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309. Cardiovasc. Res. 27: 1430-1434, 1993.
9. Kim, Y. D., R. M. Danchak, K. F. Heim, D. E. Lees, and A. K. Myers. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. Prostaglandins 46: 269-276, 1993.
10. Ko, W., A. S. Hawes, W. D. Lazenby, S. E. Calvano, Y. T. Shin, J. A. Zelano, A. C. Antonacci, O. W. Isom, and K. H. Krieger. Myocardial reperfusion injury: platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion. J. Thorac. Cardiovasc. Surg. 102: 297-308, 1991.
11. Ko, W., D. Lang, A. S. Hawes, J. A. Zelano, O. W. Isom, and K. H. Krieger. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. J. Surg. Res. 55: 504-515, 1993.
12. Ku, D. D. Coronary vascular reactivity after acute myocardial ischemia. Science Wash. DC 218: 576-578, 1982.
13. Kubes, P., G. Ibbotson, J. Russell, J. L. Wallace, and D. N. Granger. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G300-G305, 1990.
14. Kubes, P., M. Suzuki, and D. N. Granger. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G859-G864, 1990.
15. Kuo, L., M. J. Davis, M. S. Cannon, and W. M. Chilian. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ. Res. 70: 465-576, 1992.
16. Kuo, L., M. J. Davis, and W. M. Chilian. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1063-H1070, 1990.
17. Lamping, K. G., H. Kanatsuka, C. L. Eastham, W. M. Chilian, and M. L. Marcus. Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin. Circ. Res. 65: 343-351, 1989.
18. Lorant, D. E., M. K. Topham, R. E. Whatley, R. P. McEver, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. Inflammatory roles of P-selectin. J. Clin. Invest. 92: 559-570, 1993.
19. Ma, X., P. S. Tsao, G. E. Viehman, and A. M. Lefer. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ. Res. 69: 95-106, 1991.
20. Ma, X.-L., A. S. Weyrich, S. Krantz, and A. M. Lefer. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J. Pharmacol. Exp. Ther. 260: 1229-1236, 1992.
21. Mehta, J. L., W. W. Nichols, W. H. Donnelly, D. L. Lawson, and T. G. P. Saldeen. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion. Circulation 64: 43-54, 1989.
22. Montrucchio, G., G. Alloatti, F. Mariano, A. Comino, G. Cacace, R. Polloni, P. G. De Filippi, G. Emanuelli, and G. Camussi. Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. Am. J. Pathol. 142: 471-480, 1993.
23. Montrucchio, G., G. Alloatti, F. Mariano, R. De Paulis, A. Comino, G. Emanuelli, and G. Camussi. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am. J. Pathol. 137: 71-83, 1990.
24. Montrucchio, G., G. Alloatti, C. Tetta, R. De Luca, R. N. Saunders, G. Emanuelli, and G. Camussi. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am. J. Physiol. 256 (Heart Circ Physiol. 25): H1236-H1246, 1989.
25. Montrucchio, G., G. Camussi, C. Tetta, G. Emmanuelli, F. Orzan, L. Libero, and A. Brusca. Intravascular release of platelet-activating factor during atrial pacing. Lancet 2: 293, 1986.
26. Prescott, S. M., G. A. Zimmerman, and T. M. McIntyre. Platelet-activating factor. J. Biol. Chem. 265: 17381-17384, 1990.
27. Pugsley, M. K., H. Salari, and M. J. A. Walker. Actions of platelet-activating factor on isolated rat hearts. Circ. Shock 35: 207-214, 1991.
28. Quillen, J. E., F. W. Sellke, L. A. Brooks, and D. G. Harrison. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 82: 586-594, 1990.
29. Sagach, V. F., A. V. Zhukova, and P. Braquet. Endothelium-dependent effects of platelet-activating factor in the coronary circulation. J. Cardiovasc. Pharmacol. 20, Suppl. 12: S85-S89, 1992.
30. Tomeo, A. C., and W. N. Durán. Resistance and exchange microvessels are modulated by different PAF receptors. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1648-H1652, 1991.
31. Tsao, P. S., X. Ma, and A. M. Lefer. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am. Heart J. 123: 1464-1471, 1992.
32. Watanabe, M., M. Yagi, M. Omata, N. Hirasawa, S. Mue, S. Tsurufuji, and K. Ohuchi. Stimulation of neutrophil adherence to vascular endothelial cells by histamine and thrombin and its inhibition by PAF antagonists and dexamethasone. Br. J. Pharmacol. 102: 239-245, 1991.